The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics
- PMID: 15876399
- DOI: 10.1016/j.addr.2004.12.013
The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics
Abstract
Human cysteine proteases of the papain family have been recognized as potential drug targets for musculoskeletal diseases. Most of the interest is focused on cathepsins S and K, which display selective expression in cells of the immune system and cells capable to efficiently degrade extracellular matrix proteins, in particular collagens. The predominant expression of cathepsin K in osteoclasts has rendered the enzyme into a major target for the development of novel anti-resorptive drugs in osteoporosis whereas cathepsin S appears to be an attractive drug target candidate for various inflammatory diseases including rheumatoid arthritis. Since rheumatoid arthritis is at the same time an inflammatory and joint destructive disorder, the combined inhibition of both cathepsins S and K should be beneficial. This review will outline the rationale and recent progress for targeting cathepsins in arthritis and osteoporosis.
Similar articles
-
Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis.Int J Pharm. 2004 Jun 11;277(1-2):73-9. doi: 10.1016/j.ijpharm.2003.03.003. Int J Pharm. 2004. PMID: 15158970 Review.
-
Drug delivery strategies for cathepsin inhibitors in joint diseases.Expert Opin Drug Deliv. 2005 Nov;2(6):1015-28. doi: 10.1517/17425247.2.6.1015. Expert Opin Drug Deliv. 2005. PMID: 16296806 Review.
-
6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents.Prog Med Chem. 2004;42:245-375. doi: 10.1016/S0079-6468(04)42006-2. Prog Med Chem. 2004. PMID: 15003723 Review. No abstract available.
-
Cathepsin K inhibitors: a novel target for osteoporosis therapy.Clin Pharmacol Ther. 2008 Jan;83(1):172-6. doi: 10.1038/sj.clpt.6100450. Epub 2007 Dec 12. Clin Pharmacol Ther. 2008. PMID: 18073778 Review.
-
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.J Med Chem. 2004 Jan 29;47(3):588-99. doi: 10.1021/jm030373l. J Med Chem. 2004. PMID: 14736240
Cited by
-
Lysosomal biogenesis and function in osteoclasts: a comprehensive review.Front Cell Dev Biol. 2024 Aug 7;12:1431566. doi: 10.3389/fcell.2024.1431566. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39170917 Free PMC article. Review.
-
Proteomic Clustering Reveals the Kinetics of Disease Biomarkers in Bovine and Human Models of Post-Traumatic Osteoarthritis.Osteoarthr Cartil Open. 2021 Dec;3(4):100191. doi: 10.1016/j.ocarto.2021.100191. Epub 2021 Dec 16. Osteoarthr Cartil Open. 2021. PMID: 36313736 Free PMC article.
-
Inflammation-Driven Secretion Potential Is Upregulated in Osteoarthritic Fibroblast-Like Synoviocytes.Int J Mol Sci. 2022 Oct 5;23(19):11817. doi: 10.3390/ijms231911817. Int J Mol Sci. 2022. PMID: 36233118 Free PMC article.
-
Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.Mol Imaging Biol. 2023 Feb;25(1):58-73. doi: 10.1007/s11307-022-01768-4. Epub 2022 Aug 24. Mol Imaging Biol. 2023. PMID: 36002710 Free PMC article. Review.
-
Dynamic movement and turnover of extracellular matrices during tissue development and maintenance.Fly (Austin). 2022 Dec;16(1):248-274. doi: 10.1080/19336934.2022.2076539. Fly (Austin). 2022. PMID: 35856387 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
